ArticleClinical and experimental medicine2024

Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.

Naokazu Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.